NASDAQ: ISPCIspecimen Inc Stock Ownership - Who owns Ispecimen?
Insider buying vs selling
Have Ispecimen Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ISPC insiders and whales buy or sell their stock.
ISPC Shareholders
What type of owners hold Ispecimen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Andrew L. Ross | 274.94% | 3,951,388 | $10.23M | Insider |
| George H. Scholl | 58.80% | 845,106 | $2.19M | Insider |
| Obf Investments LLC | 58.59% | 841,981 | $2.18M | Insider |
| Christopher Ianelli | 29.60% | 425,359 | $1.10M | Insider |
| Geode Capital Management LLC | 21.79% | 313,098 | $810.92k | Institution |
| Jill Mullan | 17.13% | 246,226 | $637.73k | Insider |
| Benjamin Bielak | 5.87% | 84,348 | $218.46k | Insider |
| Jane Street Group LLC | 3.87% | 55,631 | $144.08k | Institution |
| Ubs Group Ag | 3.74% | 53,744 | $139.20k | Institution |
| Citadel Advisors LLC | 3.51% | 50,471 | $130.72k | Institution |
ISPC vs Diagnostic & Research Stocks
Ispecimen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.